| scholarly article | Q13442814 |
| P2093 | author name string | Sadi Bener | |
| Aylin Orgen Çallı | |||
| Bahriye Payzin | |||
| Betül Bolat Küçükzeybek | |||
| Tuğba Doğruluk Paksoy | |||
| P2860 | cites work | Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma | Q27851513 |
| Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma | Q28189412 | ||
| Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma | Q28209540 | ||
| Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Identification of a high-risk subset with coexpression of CD10 and bcl-2 | Q28211106 | ||
| A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group | Q28246957 | ||
| Ki67 protein: the immaculate deception? | Q34570709 | ||
| p53 protein expression and its prognostic importance in patients with nodal non-Hodgkin's lymphoma | Q34656579 | ||
| No Prognostic Impact of p53 and P-Glycoprotein Expression in Patients with Diffuse Large B-Cell Lymphoma | Q40235799 | ||
| BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma | Q40357519 | ||
| p53 expression in non-Hodgkin's lymphomas: a marker of p53 inactivation? | Q40540546 | ||
| Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease? | Q40719704 | ||
| bcl-2: role in epithelial differentiation and oncogenesis | Q40980403 | ||
| Characterization of genetic lesions in apoptosis-regulating and proliferation control genes in diffuse large B-cell non-Hodgkin's lymphoma | Q43160129 | ||
| Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells | Q43251898 | ||
| Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. | Q44427938 | ||
| Lack of prognostic significance of BCL2 and p53 protein overexpression in elderly patients with diffuse large B-cell non-Hodgkin's lymphoma: results from a population-based non-Hodgkin's lymphoma registry. | Q47830253 | ||
| Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas | Q49106541 | ||
| Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas. | Q53339929 | ||
| Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. | Q53357992 | ||
| Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. | Q53360777 | ||
| Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma. | Q53456604 | ||
| Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA) | Q57219095 | ||
| Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27Kip1 | Q57789025 | ||
| Human p53 gene localized to short arm of chromosome 17 | Q59074679 | ||
| Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas | Q61053586 | ||
| Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study | Q61868311 | ||
| The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity | Q67552132 | ||
| Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67 | Q68132090 | ||
| The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma | Q69022163 | ||
| Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma | Q70708997 | ||
| Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial | Q72282786 | ||
| Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins | Q74546067 | ||
| CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses | Q81419111 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 275-282 | |
| P577 | publication date | 2013-09-05 | |
| P1433 | published in | Turkish journal of hematology : official journal of Turkish Society of Haematology | Q26842860 |
| P1476 | title | Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma | |
| P478 | volume | 30 |
| Q48144174 | Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms. |
| Q38727337 | Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma. |
Search more.